Neurologic Conditions Affecting the Equine Athlete.
- Journal Article
- Review
- Clinical Examination
- Diagnosis
- Diagnostic Technique
- Disease Diagnosis
- Disease Etiology
- Disease Management
- Disease Outbreaks
- Disease Prevalence
- Disease Surveillance
- Disease Treatment
- Epidemiology
- Equine Diseases
- Equine Health
- Equine Herpesvirus
- Equine Protozoal Myeloencephalitis
- Horses
- Infection
- Infectious Disease
- Nervous System
- Neurological Diseases
- Veterinary Medicine
Summary
The research article is about the three most common neurological diseases impacting horses in the United States and how they could potentially be misidentified as orthopedic conditions due to their early symptoms, emphasizing the importance of correct diagnosis for effective treatment.
Introduction to Neurological Diseases in Horses
The article focuses on the three most prevalent neurological conditions affecting equine athletes in the United States, namely, Epmorax, CVSM, and EDM. These diseases have a higher prevalence among younger horses. They pose significant health concerns, impacting the horse’s performance, especially in competitive spaces such as horse shows.
Greater Risks for Competitive Horses
The research pointed out that equine athletes participating in shows and competitive events are more susceptible to one particularly highly contagious neurological disease called EHV-1. EHV-1 outbreaks represent concerning threats to the horse community, given their contagiousness.
Challenges in Diagnosis
- A central point raised in the article is the difficulty in correctly diagnosing these neurological diseases. This is due to the early symptoms of these conditions often mimicking or being misinterpreted as orthopedic problems.
- The article emphasizes that a clinical diagnosis of neurological diseases in equine athletes should be based on a comprehensive neurologic examination, a detailed history taking of the horse, and the correct interpretation of diagnostic tests.
The Importance of Correct Diagnosis
The research indicates that an accurate diagnosis is essential for performance-related issues in equine athletes. Implicit in this argument is the importance of understanding the unique symptoms and indications of neurological conditions rather than misdiagnosing them as orthopedic issues. This can lead towards administering necessary treatments, thus potentially improving or saving the horses’ lives.
Cite This Article
Publication
Researcher Affiliations
- Department of Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, 200 Westboro Road, North Grafton, MA 01536, USA. Electronic address: daniela.bedenice@tufts.edu.
- Department of Clinical Studies, University of Pennsylvania, School of Veterinary Medicine, New Bolton Center, 382 West Street Road, Kennett Square, PA 19348, USA.
MeSH Terms
- Animals
- Central Nervous System Diseases / diagnosis
- Central Nervous System Diseases / pathology
- Central Nervous System Diseases / veterinary
- Gait
- Horse Diseases / pathology
- Horses
- Lameness, Animal
Citations
This article has been cited 5 times.- Magouras I, Schoster A, Fouché N, Gerber V, Groschup MH, Ziegler U, Fricker R, Griot C, Vögtlin A. Neurological disease suspected to be caused by tick-borne encephalitis virus infection in 6 horses in Switzerland. J Vet Intern Med 2022 Nov;36(6):2254-2262.
- Bedenice D, Johnson AL. Neurologic conditions in the sport horse. Anim Front 2022 Jun;12(3):37-44.
- Pain B, Baquerre C, Coulpier M. Cerebral organoids and their potential for studies of brain diseases in domestic animals. Vet Res 2021 May 3;52(1):65.
- Story MR, Haussler KK, Nout-Lomas YS, Aboellail TA, Kawcak CE, Barrett MF, Frisbie DD, McIlwraith CW. Equine Cervical Pain and Dysfunction: Pathology, Diagnosis and Treatment. Animals (Basel) 2021 Feb 6;11(2).
- de Oliveira Ferreira LV, Maia L, Barberini DJ, Takahira RK, de Vasconcelos Machado VM, Machado GF, de Melo GD, Amorim RM. Feasibility and safety of intrathecal transplantation of allogeneic bone marrow mesenchymal stem cells in horses. Vet Res Commun 2025 Sep 29;49(6):333.